10 companies

Netflix

Market Cap: US$526.5b

Provides entertainment services.

New

NFLX

US$1,238.95

7D

2.3%

1Y

83.8%

Futu Holdings

Market Cap: US$24.3b

Provides digitalized securities brokerage and wealth management product distribution service in Hong Kong and internationally.

FUTU

US$174.25

7D

8.3%

1Y

183.3%

Comfort Systems USA

Market Cap: US$24.0b

Provides mechanical and electrical installation, renovation, maintenance, repair, and replacement services for the mechanical and electrical services industry in the United States.

FIX

US$680.86

7D

-1.6%

1Y

105.9%

SharkNinja

Market Cap: US$16.8b

A product design and technology company, engages in the provision of various solutions for consumers in the United States, China, and internationally.

SN

US$118.96

7D

2.5%

1Y

30.6%

Luckin Coffee

Market Cap: US$12.3b

Offers retail services of freshly brewed drinks, and pre-made food and beverage items in the People's Republic of China.

LKNC.Y

US$38.50

7D

1.1%

1Y

87.1%

Exelixis

Market Cap: US$10.3b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$38.31

7D

1.6%

1Y

45.4%

Hamilton Lane

Market Cap: US$8.7b

A private equity and venture capital firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies.

HLNE

US$155.46

7D

0.6%

1Y

8.6%

IES Holdings

Market Cap: US$6.6b

Designs and installs integrated electrical and technology systems, and provides infrastructure products and services in the United States.

IESC

US$332.16

7D

-4.0%

1Y

94.4%

Dave

Market Cap: US$2.7b

Provides various financial products and services through its financial services platform in the United States.

DAVE

US$201.39

7D

10.0%

1Y

456.3%

Harmony Biosciences Holdings

Market Cap: US$2.1b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

HRMY

US$36.87

7D

7.8%

1Y

5.5%